Wockhardt UK is one of the largest generic pharmaceutical companies in the UK and employ over 400 people at its 612,000 square feet high-tech manufacturing facility at Wrexham, North Wales.

Wockhardt UK consists of the following companies operating within the UK:

  • Wockhardt UK Ltd
  • CP Pharmaceuticals Ltd

We specialise in the supply of generic and speciality medicines and is one of the leading suppliers to the NHS.  We have a portfolio of over 250 product lines which are available in a wide range of preparations, including tablets, capsules, injections, and liquid medicines.

The UK manufacturing site produces a number of sterile injectable products covering a wide range of therapy areas including diabetes, anticoagulation, and pain management. The products are available in multiple forms such as vials, cartridges and ampoules including lyophilised (dry powder) products. In addition to our own Wockhardt branded products, we also provide contract manufacturing services for companies globally.


Slavery and human trafficking remains a hidden blight on our global society. We all have a responsibility to be alert to the risks, however small, in our business and in the wider supply chain.

Our focus on slavery and human trafficking is part of a larger effort to encourage supply chain transparency and accountability. We will not tolerate forced, bonded (including debt bondage) or indentured labour, involuntary prison labour, slavery, or trafficking of persons (referred to in this policy as “modern slavery”) by any Wockhardt UK supplier or for any other purpose. We also ensure transparency internally within Wockhardt UK, by ensuring our internal policies are in line with the Modern Slavery Act 2015 and delivering training to our employees on the relevant policies.

As a result of this training, we are confident that all our employees are fully equipped to challenge anything which they believe goes against this ethos and in turn, those who they raise their challenge with are required to act.


We are committed to ensuring that there is no modern slavery in our supply chains, internally or in any part of our business. Our Modern Slavery Policy reflects our commitment to acting ethically and with integrity in all our business relationships and to our employees and to implementing and enforcing effective systems and controls to ensure modern slavery is not taking place anywhere in our business or supply chains.


As well as having a policy in place, we recognise that a key part of that commitment is giving employees the necessary tools to enable them to identify potential issues and act upon them.

To ensure this high level of understanding of the risks of modern slavery in our supply chains and our business, modern day slavery training awareness has been rolled out to all employees, so that everyone in the business has a clear understanding of this potential issue.


Our supply chain includes the sourcing of raw materials and it is principally but not wholly related to the provision of pharmaceuticals.

We will not engage in business with any supplier or individual known to engage in practices which are in breach of the Act and take a zero-tolerance view to any suppliers who are found in breach of the Act after a contract has been awarded.

All our suppliers have received from us a Code of Conduct setting out our expectations and their obligations to ensure effective systems and controls are in place to safeguard against any form of modern slavery.

Our Directors are responsible for compliance in their respective departments and for their supplier relationships.


As part of our initiative to identify and mitigate risk we make clear our expectations of business behaviour;

With regards to national or international supply chains, our point of contact is preferably with a UK company or branch and we expect these entities to have and provide us with full details of measures they are taking to combat modern slavery.

As a minimum we insist that each entity in the chain should, at least, adopt a ‘one-up’ due diligence on the next link in the chain.

We have in place systems to encourage the reporting of concerns and the protection of whistle blowers, and our employees are suitably trained.


We use the following key performance indicators (KPIs) to measure how effective we have been to ensure that modern slavery is not taking place in any part of our business or supply chains:

  • Completion of in-house Audits by managers;
  • Use of labour monitoring and payroll systems;
  • Level of communication and personal contact with supply chain and their understanding of, and compliance with our expectations.

This statement is made pursuant to section 54(1) of the Modern Slavery Act 2015 and constitutes our group’s statement for the financial year ending 31st March 2024.

The statement is approved by the Board of Directors.

Signed by the Managing Director

Director Signature

Last updated:  28th March 2024